201 related articles for article (PubMed ID: 20540627)
1. Integration of in silico and in vitro platforms for pharmacokinetic-pharmacodynamic modeling.
Sung JH; Esch MB; Shuler ML
Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1063-81. PubMed ID: 20540627
[TBL] [Abstract][Full Text] [Related]
2. A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip.
Sung JH; Kam C; Shuler ML
Lab Chip; 2010 Feb; 10(4):446-55. PubMed ID: 20126684
[TBL] [Abstract][Full Text] [Related]
3. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
Gabrielsson J; Green AR
J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
[TBL] [Abstract][Full Text] [Related]
4. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.
Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA
Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.
Danhof M; de Lange EC; Della Pasqua OE; Ploeger BA; Voskuyl RA
Trends Pharmacol Sci; 2008 Apr; 29(4):186-91. PubMed ID: 18353445
[TBL] [Abstract][Full Text] [Related]
6. Functional mapping of drug response with pharmacodynamic-pharmacokinetic principles.
Ahn K; Luo J; Berg A; Keefe D; Wu R
Trends Pharmacol Sci; 2010 Jul; 31(7):306-11. PubMed ID: 20488563
[TBL] [Abstract][Full Text] [Related]
7. Mathematical modeling of drug delivery.
Siepmann J; Siepmann F
Int J Pharm; 2008 Dec; 364(2):328-43. PubMed ID: 18822362
[TBL] [Abstract][Full Text] [Related]
8. The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies.
Muller PY; Milton M; Lloyd P; Sims J; Brennan FR
Curr Opin Biotechnol; 2009 Dec; 20(6):722-9. PubMed ID: 19896825
[TBL] [Abstract][Full Text] [Related]
9. Nociceptive stimulus modality-related difference in pharmacokinetic-pharmacodynamic modeling of morphine in the rat.
Shang GW; Liu DN; Yan LH; Cui XY; Zhang KP; Qi C; Chen J
Pharmacol Biochem Behav; 2006 Oct; 85(2):464-73. PubMed ID: 17126387
[TBL] [Abstract][Full Text] [Related]
10. [Role of pharmacokinetic-pharmacodynamic relationships in drug development].
Bellissant E; Courcier-Duplantier S; Blin O;
Therapie; 2002; 57(4):347-57. PubMed ID: 12422555
[TBL] [Abstract][Full Text] [Related]
11. Early prediction of drug metabolism and toxicity: systems biology approach and modeling.
Bugrim A; Nikolskaya T; Nikolsky Y
Drug Discov Today; 2004 Feb; 9(3):127-35. PubMed ID: 14960390
[TBL] [Abstract][Full Text] [Related]
12. The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development.
Yu XQ; Wilson AG
Future Med Chem; 2010 Jun; 2(6):923-8. PubMed ID: 21426110
[No Abstract] [Full Text] [Related]
13. Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology.
Rostami-Hodjegan A
Clin Pharmacol Ther; 2012 Jul; 92(1):50-61. PubMed ID: 22644330
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic modeling in vivo.
Holford NH; Sheiner LB
Crit Rev Bioeng; 1981; 5(4):273-322. PubMed ID: 7023829
[TBL] [Abstract][Full Text] [Related]
15. In vitro measurements of metabolism for application in pharmacokinetic modeling.
Lipscomb JC; Poet TS
Pharmacol Ther; 2008 Apr; 118(1):82-103. PubMed ID: 18374419
[TBL] [Abstract][Full Text] [Related]
16. In vitro microscale systems for systematic drug toxicity study.
Sung JH; Shuler ML
Bioprocess Biosyst Eng; 2010 Jan; 33(1):5-19. PubMed ID: 19701779
[TBL] [Abstract][Full Text] [Related]
17. Physiologically based pharmacokinetics (PBPK).
Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetic (PBPK) modeling in children.
Barrett JS; Della Casa Alberighi O; Läer S; Meibohm B
Clin Pharmacol Ther; 2012 Jul; 92(1):40-9. PubMed ID: 22669290
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation.
Chien JY; Friedrich S; Heathman MA; de Alwis DP; Sinha V
AAPS J; 2005 Oct; 7(3):E544-59. PubMed ID: 16353932
[TBL] [Abstract][Full Text] [Related]
20. Technologies for Measuring Pharmacokinetic Profiles.
Heller AA; Lockwood SY; Janes TM; Spence DM
Annu Rev Anal Chem (Palo Alto Calif); 2018 Jun; 11(1):79-100. PubMed ID: 29324183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
